Literature DB >> 27592306

Nodal signaling modulates the expression of Oct-4 via nuclear translocation of β-catenin in lung and prostate cancer cells.

Yi-Fei Qi1, Long Wu2, Zi-Qian Li1, Meng-Ling Wu1, Hai-Fang Wang1, Ka-Ying Chan1, Lin-Lin Lu1, Shao-Hui Cai2, Hong-Sheng Wang3, Jun Du4.   

Abstract

Nodal is a member of transforming growth factor beta (TGF-β) superfamily. Nodal promotes the self-renewal of human cancer stem cells (CSCs) and triggers carcinogenesis of human cancers via an autocrine manner through Smad2/3 pathway. In our study, generation of Nodal-overexpressed cancer cells was constructed, and the effect of Nodal on the stem cell marker Oct-4 was evaluated by overexpression or blocked Nodal/ALKs signaling pathway in non-small cell lung cancer cells A549 and prostate cancer cells PC3. Functionally, Nodal also increased the proliferation via the β-catenin nuclear translocation. This increase was attributed to GSK-3β dephosphorylating, and activin receptor-like kinase 4/7 (ALK4/7) played a major role in human cancer cells. Our study provides a positive understanding of Nodal function in cancer cells and suggests a potential novel target for clinical therapeutic research.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALK4/7; Nodal; Oct-4; Wnt/β-catenin signaling pathways

Mesh:

Substances:

Year:  2016        PMID: 27592306     DOI: 10.1016/j.abb.2016.07.003

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  6 in total

1.  Nodal pathway activation due to Akt1 suppression is a molecular switch for prostate cancer cell epithelial-to-mesenchymal transition and metastasis.

Authors:  Abdulrahman Alwhaibi; Arti Verma; Sandeep Artham; Mir S Adil; Payaningal R Somanath
Journal:  Biochem Pharmacol       Date:  2019-06-14       Impact factor: 5.858

2.  Reciprocal control of lncRNA-BCAT1 and β-catenin pathway reveals lncRNA-BCAT1 long non-coding RNA acts as a tumor suppressor in colorectal cancer.

Authors:  Fei Xie; Xudong Xiang; Qionglin Huang; Pengzhan Ran; Yuncang Yuan; Qian Li; Guoxiang Qi; Xiaopeng Guo; Chunjie Xiao; Shangyong Zheng
Journal:  Oncotarget       Date:  2017-04-04

3.  Nodal Facilitates Differentiation of Fibroblasts to Cancer-Associated Fibroblasts that Support Tumor Growth in Melanoma and Colorectal Cancer.

Authors:  Ziqian Li; Junjie Zhang; Jiawang Zhou; Linlin Lu; Hongsheng Wang; Ge Zhang; Guohui Wan; Shaohui Cai; Jun Du
Journal:  Cells       Date:  2019-06-04       Impact factor: 6.600

4.  Octamer binding transcription factor-4 expression is associated with cervical cancer malignancy and histological differentiation: a systematic review and meta-analysis.

Authors:  Zi-Ye Gao; Xiao-Bo Liu; Feng-Mei Yang; Ling Liu; Jin-Zhang Zhao; Bo Gao; Sheng-Bao Li
Journal:  Biosci Rep       Date:  2019-05-10       Impact factor: 3.840

5.  XIAOPI Formula Inhibits Breast Cancer Stem Cells via Suppressing Tumor-Associated Macrophages/C-X-C Motif Chemokine Ligand 1 Pathway.

Authors:  Shengqi Wang; Xiaoyan Liu; Renlun Huang; Yifeng Zheng; Neng Wang; Bowen Yang; Honglin Situ; Yi Lin; Zhiyu Wang
Journal:  Front Pharmacol       Date:  2019-11-15       Impact factor: 5.810

6.  Biological effects of NODAL on endometrial cancer cells and its underlying mechanisms.

Authors:  Xiaoshan Hong; Bin Wen; Huaming Zhang; Yuhan Li; Hengying Wu; Wei Zhao; Xiping Luo
Journal:  Exp Ther Med       Date:  2021-02-25       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.